Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States

Figure 1

Economic model structure. OS = overall survival curve; PFS = progression-free survival curve. Note that the PFS and OS curves shown are illustrative only.